Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company ...
Classic Mac OS was prized for its clean, accessible GUI when it first hit the scene in the 1980s. Back then, developers hadn’t even conceived of all the weird gewgaws that would eventually ...
A quarter of a century after IBM released the last official version of OS/2, someone is still keeping the platform alive under the ArcaOS name. Arca ...
Whether the MacBook Neo proves to be a disruptive force or remains a niche offering will become clear over time. For now, the question of buying a Mac is increasingly entering mainstream conversation ...